Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-121,200
Closed -$6.33M 1627
2019
Q4
$6.33M Hold
121,200
0.01% 850
2019
Q3
$6.12M Hold
121,200
0.01% 810
2019
Q2
$5.82M Hold
121,200
﹤0.01% 907
2019
Q1
$5.87M Buy
+121,200
New +$5.47M 0.01% 847

Other funds holding HOLX

Amundi Asset Management US's HOLX Position: Q1 2021 in Review

Amundi Asset Management US reduced its Hologic (HOLX) stake by 38% in Q1 2021, selling an estimated $31.5M and leaving 686,540 shares worth $51.1M. The position accounts for 0.04% of the portfolio, ranked #412.

Amundi Asset Management US first reported a position in HOLX in Q2 2013 and has held it in 24 quarters since. The position peaked at $111M in Q2 2020. 638 funds tracked by Wall St. Rank hold HOLX as of Q1 2021.

  • Amundi Asset Management US held 686,540 shares of Hologic worth $51.1M as of Q1 2021.
  • Amundi Asset Management US sold 414,516 Hologic shares in Q1 2021, an estimated $31.5M.
  • Hologic made up 0.04% of Amundi Asset Management US's portfolio in Q1 2021, its #412 holding.
  • Amundi Asset Management US first reported a position in Hologic in Q2 2013 and has held it in 24 quarters since.
  • Amundi Asset Management US's Hologic position peaked at $111M in Q2 2020.
  • 638 funds tracked by Wall St. Rank held Hologic as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.